Related Experiment Videos
Weight and consequences of post-marketing (-approval) experience
1Bundesinstitut für Arzneimittel und Medizinprodukte, Department of Clinical Pharmacology Devices, Friedrich-Ebert-Allee 38, D-53113 Bonn, Germany.
Annals of the Rheumatic Diseases
|October 16, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adherence to treatment of osteoporosis: a need for study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007
[Contribution of psychomotricity in respiratory rehabilitation programs].
Revue des maladies respiratoires·2007
[Clinical trials for medicinal products. New European and national legal rules].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2005
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.
Osteoarthritis and cartilage·2005
The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2002
Background for studies on the treatment of male osteoporosis: state of the art.
Annals of the rheumatic diseases·2000
Zanubrutinib monotherapy for IgG4-related head and neck disease.
Annals of the rheumatic diseases·2026
Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus.
Annals of the rheumatic diseases·2026
Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.
Annals of the rheumatic diseases·2026
Unintended Financial Barriers: When "Generic" Does Not Mean Affordable.
Journal of cardiac failure·2026
Evaluating factors associated with pharmaceutical price variation, dispersion and higher-tier pricing in Malaysia's public segmented procurement system: exploring market competition.
Journal of pharmaceutical policy and practice·2026